What is PTC Therapeutics's PP&E (net)?

PTC Therapeutics (PTCT) reported PP&E (net) of $52.74M in Q1 2026.

How has PTC Therapeutics's PP&E (net) changed year-over-year?

PTC Therapeutics's PP&E (net) decreased by 11.3% year-over-year, from $59.46M to $52.74M.

What is the long-term trend for PTC Therapeutics's PP&E (net)?

Over 5 years (2020 to 2025), PTC Therapeutics's PP&E (net) has grown at a 10.4% compound annual growth rate (CAGR), from $33.83M to $55.37M.

What does PP&E (net) mean?

Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.

PTC Therapeutics PTCT PP&E (Net)

PP&E (Net) at other companies

BioMarin PharmaceuticalsBMRN

$958.07M-7.2%

BridgeBio PharmaBBIO

$4.94M-26.2%

Arrowhead ResearchARWR

$374.82M-2.6%

United TherapeuticsUTHR

$1.84B+41.3%

BiogenBIIB

$3.02B-3.7%

ALN

Alnylam PharmaceuticalsALNY

——

Segments

By geography

See full

US$59.75M—

Other financials

Income statement

See full

Revenue$272.6M-76.8%

Operating income$45.0M-95.4%

Net income-$2.8M-100%

EPS (diluted)-$0.03-100%

Balance sheet

See full

Cash & equivalents$834.0M-43.7%

Total debt$395.1M+0.1%

Total equity-$180.5M+2.9%

Total assets$2.9B+8.0%

Cash flow

See full

Operating cash flow-$59.0M-107%

CapEx$1.2M-30.6%

Free cash flow-$60.2M-107%

Valuation

See full

Market cap$6.55B+40.3%

Enterprise value$6.11B+77.3%

P/E8×—

P/S7.9×+5.3×

Profitability

See full

Gross margin96%—

Operating margin1.6%-38.7pp

Net margin42.3%+27.4pp

FCF margin39.1%+32.8pp

Returns & leverage

See full

Return on equity-216.7%—

Debt / equity372.3×—

Current ratio2.4×-1.5×

Where this comes from

Reported directly by PTC Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.

The official record: PTC Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about PTC Therapeutics's pp&e (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is PTC Therapeutics's PP&E (net)?: PTC Therapeutics (PTCT) reported PP&E (net) of $52.74M in Q1 2026.
How has PTC Therapeutics's PP&E (net) changed year-over-year?: PTC Therapeutics's PP&E (net) decreased by 11.3% year-over-year, from $59.46M to $52.74M.
What is the long-term trend for PTC Therapeutics's PP&E (net)?: Over 5 years (2020 to 2025), PTC Therapeutics's PP&E (net) has grown at a 10.4% compound annual growth rate (CAGR), from $33.83M to $55.37M.
What does PP&E (net) mean?: Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.